Hormones of the hypothalamic-pituitary-gonadal (HPG) axis in male depressive disorders - A systematic review and meta-analysis

Front Neuroendocrinol. 2019 Oct:55:100792. doi: 10.1016/j.yfrne.2019.100792. Epub 2019 Sep 23.

Abstract

Sexual dysfunctions are common in men with depression. As the hypothalamic-pituitary-gonadal (HPG) axis is a crucial regulator of sexual function, and also affects mood and cognition, the following question arises: Is the HPG axis altered in depressed men when compared to healthy controls? To answer this question, PubMed and PsycINFO were searched. Inclusion criteria for the systematic review and meta-analysis were: (1) case-control study including male patients with a depressive disorder and (2) assessment of follicle-stimulating hormone (FSH), luteinising hormone (LH), oestradiol, or testosterone. Seventeen studies were identified. Follicle-stimulating hormone and LH did not differ between patients and controls. By contrast, in patients, oestradiol was marginally increased (g = 0.52, 95% CI [-0.01, 1.04]; Z = 1.92, p = .055) and testosterone was significantly decreased (g = -0.45, 95% CI [-0.80, -0.10]; Z = -2.53, p = .012). Depressed men may be characterised by diminished testosterone and potentially elevated oestradiol, which beyond contributing to sexual dysfunction, could impact mood and cognition.

Keywords: Depression; Follicle-stimulating hormone; Luteinising hormone; Male; Oestradiol; Testosterone.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Depressive Disorder / metabolism*
  • Estradiol / metabolism*
  • Follicle Stimulating Hormone / metabolism*
  • Humans
  • Hypothalamo-Hypophyseal System / metabolism*
  • Luteinizing Hormone / metabolism*
  • Male
  • Testosterone / metabolism*

Substances

  • Testosterone
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone